CLX Medical, Inc.
Company: CLX Medical, Inc.
Website: clxmedical.com
OTCBB: CLXN
CLX Medical, Inc. holds a 51% equity interest in Zonda, Inc, which has developed several rapid point-of-care tests for medical and non-medical markets, including a rapid test for chlamydia. CLX has also entered into a definitive agreement to acquire ThyroTest®, a rapid thyroid stimulating hormone (TSH) screening device used for the detection of hypothyroidism in adults, a common thyroid disease. CLX Medical is focused on the successful worldwide distribution of these and any additional products it may acquire or license.
Sign up for the FREE 1000 Penny Stocks newsletter today, and get little-known investment strategies FREE! Sign up Here - Your email address 100% safe & secure.